Clinical Trial Update: Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to Syntometrine for prevention of postpartum hemorrhage after cesarean section; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)
• Syntometrine (oxytocin/ergometrine)

Snippet

Sponsor: Cairo University | Conditions: Postpartum Hemorrhage, Blood Loss | Phase 4 | Status: COMPLETED